Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbial cell membranes and their associated transport systems are critical structures that maintain the physiological integrity and metabolic functions of bacteria, fungi, and protozoa (StatPearls, 2023). These membranes serve as a selective barrier, while transport systems like ABC transporters and efflux pumps regulate the movement of nutrients, ions, and waste products (PubMed, PMID: 25745872). In the context of infectious diseases, these systems are vital for pathogen survival and are frequently involved in antimicrobial resistance by actively pumping out antibiotics (NIH, 2021). Therapeutic agents such as polymyxins and daptomycin target the physical structure of the membrane to cause leakage and cell death, while others like azoles target the biosynthetic pathways of membrane components (PubChem). However, the similarity between certain microbial and host membrane components can lead to significant toxicity, such as nephrotoxicity, making the development of highly selective membrane-targeting drugs a major challenge (PubMed, PMID: 28214562). This target entry is considered a broad category or system rather than a single specific molecular target.
Drugs targeting these systems typically act by disrupting membrane integrity through detergent-like effects (e.g., polymyxins), forming ion-conducting pores (e.g., amphotericin B), inhibiting the synthesis of essential membrane lipids like ergosterol (e.g., azoles), or blocking efflux pumps to restore antibiotic sensitivity (PubMed, PMID: 30245130; StatPearls, 2023).
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial cell membrane and membrane transport systems.